Advertisement

Clostridia and Bacteroides in Enteric Infections

  • David M. Lyerly
  • Roger L. van Tassell
  • Tracy D. Wilkins
Part of the Infectious Agents and Pathogenesis book series (IAPA)

Abstract

The ability of anaerobic bacteria to cause disease in humans and animals has been recognized for many years. The clostridia, for example, are well known for their ability to cause disease by producing a variety of toxins ranging from the potent neurotoxins of Clostridium tetani and Clostridium botulinum to the tissue-damaging toxins of the gas gangrene clostridia. Bacteroides fragilis, on the other hand, represents the major anaerobic pathogen in clinical specimens from patients with abscesses and soft-tissue infections. More recently, the importance of members of these genera in gastrointestinal infections has become recognized. Clostridium difficile has emerged as the major cause of nosocomial diarrhea because of its ability to produce diarrhea and pseudomembranous colitis in patients treated with antibiotics. Clostridium perfringens, which is the major cause of gas gangrene, produces a diverse group of toxins that are involved in enteric disease. In industrialized countries, outbreaks of C. perfringens food poisoning occur because of the production of a spore-associated enterotoxin. In certain regions in the Pacific rim, especially in Papua New Guinea, a disease known as pigbel, which is prevalent in persons who eat improperly cooked pork, results from infection with C. perfringens type C strains that produce β-toxin. In addition to these maladies, type E strains of C. perfringens and certain strains of Clostridium spiroforme produce a toxin (iota) that results in another distinctive type of enterotoxemia in animals.

Keywords

Food Poisoning Clostridium Difficile Clostridium Perfringens Pseudomembranous Colitis Toxigenic Strain 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Borriello, S. P., 1985, Clostridia in Gastrointestinal Disease, CRC Press, Boca Raton, FL.Google Scholar
  2. Finegold, S. M., and George, W. L., 1989, Anaerobic Infections in Humans, Academic Press, San Diego.Google Scholar
  3. Hatheway, C. L., 1990, The toxigenic Clostridia, Clin. Microbiol. Rev. 3:66–98.PubMedGoogle Scholar
  4. McClane, B. A., Hann, P. C., and Wnek, A. P., 1988, Clostridium perfringens enterotoxin, Microb. Pathog. 4:317–323.PubMedCrossRefGoogle Scholar
  5. Rolfe, R. D., and Finegold, S. M., 1988, Clostridium difficile: Its Role in Intestinal Disease, Academic Press, San Diego.Google Scholar
  6. Rood, J. I., and Cole, S. T., 1991, Molecular genetics and pathogenesis of Clostridium perfringens, Microbiol. Rev. 55:621–648.PubMedGoogle Scholar
  7. Sebald, M., 1992, Genetics and Molecular Biology of Anaerobic Bacteria, Springer-Verlag, Berlin.Google Scholar

References

  1. 1.
    Rolfe, R. D., and Finegold, S. M., 1988, Clostridium difficile: Its Role in Intestinal Disease, Academic Press, San Diego.Google Scholar
  2. 2.
    McFarland, L. V., Mulligan, M. E., Kwok, R. Y. Y., and Stamm, W. E., 1991, Nosocomial acquisition of Clostridium difficile infection, N. Engl. J. Med. 320:204–210.CrossRefGoogle Scholar
  3. 3.
    Lyerly, D. M., and Wilkins, T. D., 1991, Toxins of anaerobes, in: Anaerobic Microbiology, a Practical Approach (P. N. Levett, ed.), IRL Press, New York, pp. 163–181.Google Scholar
  4. 4.
    Just, I., Fritz, G., Aktories, K., Giry, M., Popoff, M., Boquet, P., Hegenbarth, S., and von Eichel-Streiber, C., 1994, Clostridium difficile toxin B acts on the GTP-binding protein rho, J. Biol. Chem. 269:10706–10712.PubMedGoogle Scholar
  5. 5.
    Dove, C. H., Wang, S.-Z., Price, S. B., Phelps, C. J., Lyerly, D. M., Wilkins, T. D., and Johnson, J. L., 1990, Molecular characterization of the Clostridium difficile toxin A gene, Infect. Immun. 58:480–488.PubMedGoogle Scholar
  6. 6.
    Barroso, L. A., Wang, S.-Z., Phelps, C. J., Johnson, J. L., and Wilkins, T. D., 1990, Nucleotide sequence of Clostridium difficile toxin B gene, Nucl. Adds Res. 18:4004.CrossRefGoogle Scholar
  7. 7.
    Martinez, R. D., and Wilkins, T. D., 1992, Comparison of Clostridium sordellii toxins HT and LT with toxins A and B of Clostridium difficile, J. Med. Microbiol. 36:30–36.PubMedCrossRefGoogle Scholar
  8. 8.
    Lyerly, D. M., Phelps, C. J., Toth, J., and Wilkins, T. D., 1986, Characterization of toxins A and B of Clostridium difficile with monoclonal antibodies, Infect. Immun. 54:70–76.PubMedGoogle Scholar
  9. 9.
    Van Damme-Jongsten, M., Rodhouse, J., Gilbert, R. J., and Notermans, S., 1990, Synthetic DNA probes for detection of enterotoxigenic Clostridium perfringens strains isolated from outbreaks of food poisoning, J. Clin. Microbiol. 28:131–133.PubMedGoogle Scholar
  10. 10.
    Duncan, C. L., and Strong, D. H., 1968, Improved medium for sporulation of Clostridium perfringens, Appl. Microbiol. 16:82–89.PubMedGoogle Scholar
  11. 11.
    Hanna, P. C., Wieckowski, E. U., Mietzner, T. A., and McClane, B. A., 1992, Mapping of functional regions of Clostridium perfringens type A enterotoxin, Infect. Immun. 60:2110–2114.PubMedGoogle Scholar
  12. 12.
    Granum, P. E., and Stewart, G. S. A. B., 1992, Molecular biology of Clostridium perfringens enterotoxin, in: Genetics and Molecular Biology of Anaerobic Bacteria (M. Sebald, ed.) Springer-Verlag, Berlin, pp. 235–247.Google Scholar
  13. 13.
    Sakurai, J., and Fujii, U., 1987, Purification and characterization of Clostridium perfringens beta toxin, Toxicon 25:1301–1310.PubMedCrossRefGoogle Scholar
  14. 14.
    Finegold, S. M., and George, W. L., 1989, Anaerobic Infections in Humans, Academic Press, San Diego.Google Scholar
  15. 15.
    Stiles, B. G., and Wilkins, T. D., 1986, Clostridium perfringens iota toxin: Synergism between two proteins, Toxicon 24:767–773.PubMedCrossRefGoogle Scholar
  16. 16.
    Stiles, B. G., and Wilkins, T. D., 1986, Purification and characterization of Clostridium perfringens iota toxin: Dependence on two nonlinked proteins for biological activity, Infect. Immun. 54:683–688.PubMedGoogle Scholar
  17. 17.
    Popoff, M. R., and Bouquet, P., 1988, Clostridium spiroforme toxin is a binary toxin which ADP-ribosylates cellular actin, Biochem. Biophys. Res. Commun. 152:1361–1368.PubMedCrossRefGoogle Scholar
  18. 18.
    Carman, R. J., Van Tassell, R. L., and Wilkins, T. D., 1987, Production of iota toxin by Clostridium spiroforme. A requirement for divalent cations, Vet. Microbiol. 15:115–120.PubMedCrossRefGoogle Scholar
  19. 19.
    Popoff, M. R., Rubin, E. J., Gill, D. M., and Boquet, P., 1988, Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain, Infect. Immun. 56:2299–2306.PubMedGoogle Scholar
  20. 20.
    Perelle, S., Gibert, M., Boquet, P., and Popoff, M. R., 1993, Characterization of Clostridium perfringens iota-toxin genes and expression in Escherichia coli, Infect. Immun. 61:5147–5156.PubMedGoogle Scholar
  21. 21.
    Sack, R. B., Albert, M. J., Alam, K., Neogi, P. K. B., and Akbar, M. S., 1994, Isolation of enterotoxigenic Bacteroides fragilis from Bangladeshi children with diarrhea: A controlled study, J. Clin. Microbiol. 32:960–963.PubMedGoogle Scholar
  22. 22.
    Weikel, C. S., Grieco, E D., Reuben, J., Myers, L. L., and Sack, R. B., 1992, Human colonic epithelial cells, HT29/C1, treated with crude Bacteroides fragilis enterotoxin dramatically alter their morphology, Infect. Immun. 60:321–327.PubMedGoogle Scholar
  23. 23.
    Van Tassell, R. L., Lyerly, D. M., and Wilkins, T. D., 1992, Purification and characterization of an enterotoxin from Bacteroides fragilis, Infect. Immun. 60:1343–1350.PubMedGoogle Scholar
  24. 24.
    Moncrief, J. S., and Van Tassell, R. L., personal communication.Google Scholar

Copyright information

© Springer Science+Business Media New York 1996

Authors and Affiliations

  • David M. Lyerly
    • 1
  • Roger L. van Tassell
    • 2
  • Tracy D. Wilkins
    • 3
  1. 1.Corporate Research CenterTechLab, Inc.BlacksburgUSA
  2. 2.Virginia Polytechnic Institute and State UniversityBlacksburgUSA
  3. 3.Fralin Biotechnology CenterVirginia Polytechnic Institute and State UniversityBlacksburgUSA

Personalised recommendations